Integrated management of safety and efficacy for drugs and bioequivalence testing eyed
Published: 2004-02-04 06:58:00
Updated: 2004-02-04 06:58:00
The Korea Food and Drug Administration has recently announced that a series of measures, such as streamlined affairs covering management of safety and efficacy for drugs and bioequivalence testing, have been finally adopted to reform its drug-related administration organizations.
The restructu...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
